Prove your efficacy and effectiveness in clinical studies with statistical analysis.
Biostatistics is necessary for all investigational drug or device development programmes to determine the efficacy and effectiveness in clinical trials. This includes the study designs, study conduct, determining the most effective data collection points and how analysis and reporting should be performed.
Quanticate’s biostatisticians have a desire for quality and implement the best approach to a client situation/scenario to ensure correct analysis without an over complex process. By using the appropriate tools, we are able to demonstrate the efficacy of a drug and present the results in the clearest way possible.
Ensure you have the best chance of success in proving your efficacy and safety with our expert biostatisticians
Receive support with your Investigational New Drug (IND) submission.
Improve your drug development efficiency with Interim Analyses.
Learn how to prepare your ISS/ISE for regulatory submissions.
Discover the benefits of the Bayesian framework for Phase II studies
Address - UK HQ:
Address - US HQ:
© 2022 Quanticate